| calcium channel, voltage-dependent, beta 4 subunit |
NITRENDIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000383uM |
.000246uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
NITRENDIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000383uM |
.000246uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
NITRENDIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000383uM |
.000246uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
NITRENDIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000383uM |
.000246uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
NITRENDIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000383uM |
.000246uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
NITRENDIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000383uM |
.000246uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
NITRENDIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000383uM |
.000246uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
NITRENDIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000383uM |
.000246uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
NITRENDIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000383uM |
.000246uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
NITRENDIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000383uM |
.000246uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
NITRENDIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000383uM |
.000246uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
NITRENDIPINE |
Calcium Channel Type L, Dihydropyridine |
100% |
.000383uM |
.000246uM |
View
|
| adrenergic receptor, alpha 1b |
QUETIAPINE |
Adrenergic alpha1B |
100% |
.0245uM |
.0136uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
PROMAZINE |
Adrenergic alpha1D |
100% |
.013uM |
.00618uM |
View
|
| adrenergic receptor, alpha 2b |
PROMAZINE |
Adrenergic alpha2B |
100% |
.018uM |
.008418uM |
View
|
| adrenergic receptor, alpha 2b |
METERGOLINE |
Adrenergic alpha2B |
100% |
.016uM |
.007516uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
SULINDAC SULFONE |
Aldose Reductase |
100% |
.269uM |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
PAROXETINE |
Adrenergic, Norepinephrine Transporter |
100% |
.086uM |
.086uM |
View
|
| cholinergic receptor, muscarinic 5 |
PAROXETINE |
Muscarinic M5 |
100% |
.123uM |
.089uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
PAROXETINE |
Serotonin Transporter |
100% |
.00008uM |
.000043uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
SUMATRIPTAN |
Serotonin 5-HT1B |
100% |
.018uM |
.008191uM |
View
|
| opioid receptor, delta 1 |
NALTREXONE |
Opiate delta |
100% |
.251uM |
.088uM |
View
|
| opioid receptor, kappa 1 |
NALTREXONE |
Opiate kappa |
100% |
.018uM |
.007175uM |
View
|
| sodium channel, voltage-gated, type X, alpha |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| sodium channel, voltage-gated, type IX, alpha |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| sodium channel, voltage gated, type VIII, alpha |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| protein kinase C, theta |
PACLITAXEL |
Phorbol Ester |
19% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| sodium channel, voltage-gated, type IV, alpha |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| sodium channel, voltage-gated, type III, alpha |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| sodium channel, voltage-gated, type II, beta |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| sodium channel, voltage-gated, type I, beta |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| adrenergic receptor, alpha 1b |
PROCHLORPERAZINE |
Adrenergic alpha1B |
100% |
.089uM |
.049uM |
View
|
| adrenergic receptor, alpha 2b |
PROCHLORPERAZINE |
Adrenergic alpha2B |
100% |
.01uM |
.004741uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
PROCHLORPERAZINE |
Serotonin 5-HT2A |
100% |
.007062uM |
.002018uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
PINDOLOL |
Serotonin 5-HT1A |
100% |
.048uM |
.027uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
PRAZOSIN |
Adrenergic alpha1D |
100% |
.000656uM |
.000323uM |
View
|
| adrenergic receptor, alpha 2a |
PROCHLORPERAZINE |
Adrenergic alpha2A |
100% |
.169uM |
.063uM |
View
|
| adrenergic receptor, alpha 1a |
PRAZOSIN |
Adrenergic alpha1A |
100% |
.000218uM |
.000088uM |
View
|
| adrenergic receptor, beta 2 |
PINDOLOL |
Adrenergic beta2 |
100% |
.000549uM |
.000377uM |
View
|
| adrenergic receptor, alpha 2b |
PROCHLORPERAZINE |
Adrenergic alpha2C |
100% |
.082uM |
.012uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
PROCHLORPERAZINE |
Adrenergic alpha2C |
100% |
.082uM |
.012uM |
View
|
| dopamine receptor D3 |
PROCHLORPERAZINE |
Dopamine D3 |
100% |
.013uM |
.004454uM |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
PRAZOSIN |
Protease, Matrix Metalloprotease-1 (MMP-1) |
100% |
4.036uM |
NoneNone |
View
|
| dopamine receptor D1A |
METERGOLINE |
Dopamine D1 |
100% |
.074uM |
.037uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
METERGOLINE |
Serotonin 5-HT2B |
100% |
.000442uM |
.000281uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel associated protein 1 |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel associated protein 2 |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type III, beta |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type IX, alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| amiloride-sensitive cation channel 5, intestinal |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type III, beta |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type I, beta |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type II, beta |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, nonvoltage-gated 1 gamma |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, nonvoltage-gated 1 beta |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, nonvoltage-gated 1, gamma |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, nonvoltage-gated 1, delta |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type X, alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type IX, alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage gated, type VIII, alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type IV, beta |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type IV, alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type III, alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type II, beta |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type I, beta |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| sodium channel, voltage-gated, type I, alpha |
METERGOLINE |
Sodium Channel, Site 2 |
100% |
.792uM |
.723uM |
View
|
| adrenergic receptor, alpha 1a |
METERGOLINE |
Adrenergic alpha1A |
100% |
.095uM |
.038uM |
View
|
| dopamine receptor D1A |
MICONAZOLE |
Dopamine D1 |
100% |
6.247uM |
3.124uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
MICONAZOLE |
Adrenergic, Norepinephrine Transporter |
100% |
2.939uM |
2.915uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
MICONAZOLE |
Dopamine Transporter |
100% |
1.701uM |
1.352uM |
View
|
| tachykinin receptor 2 |
MICONAZOLE |
Tachykinin NK2 |
100% |
4.839uM |
1.613uM |
View
|
| 5-hydroxytryptamine receptor 6 |
MICONAZOLE |
Serotonin 5-HT6 |
100% |
10.887uM |
5.055uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
MICONAZOLE |
Serotonin Transporter |
100% |
.778uM |
.414uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
PIPAMAZINE |
Serotonin 5-HT2C |
100% |
.022uM |
.011uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
PIPAMAZINE |
Serotonin 5-HT2A |
100% |
.001938uM |
.000554uM |
View
|
| adrenergic receptor, alpha 2b |
PIPAMAZINE |
Adrenergic alpha2B |
100% |
.001722uM |
.000786uM |
View
|
| dopamine receptor D3 |
CYPROHEPTADINE |
Dopamine D3 |
100% |
.048uM |
.016uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
CYPROHEPTADINE |
Adrenergic alpha1D |
100% |
.107uM |
.053uM |
View
|
| dopamine receptor D1A |
PIPAMAZINE |
Dopamine D1 |
100% |
.032uM |
.016uM |
View
|
| 5-hydroxytryptamine receptor 6 |
PIPAMAZINE |
Serotonin 5-HT6 |
100% |
.112uM |
.052uM |
View
|
| cholinergic receptor, muscarinic 1 |
CYPROHEPTADINE |
Muscarinic M1 |
100% |
.016uM |
.003943uM |
View
|
| cholinergic receptor, muscarinic 4 |
CYPROHEPTADINE |
Muscarinic M4 |
100% |
.016uM |
.002186uM |
View
|
| histamine receptor H 1 |
CYPROHEPTADINE |
Histamine H1, Central |
100% |
.0037uM |
.00043uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
CYPROHEPTADINE |
Serotonin 5-HT2A |
100% |
.000973uM |
.000278uM |
View
|
| adrenergic receptor, alpha 2a |
GUANABENZ |
Imidazoline I2, Central |
100% |
.018uM |
.012uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
GUANABENZ |
Imidazoline I2, Central |
100% |
.018uM |
.012uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
GUANABENZ |
Serotonin 5-HT2B |
100% |
.097uM |
.062uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
S-(-)-PROPRANOLOL |
Serotonin 5-HT1A |
100% |
.124uM |
.071uM |
View
|
| adrenergic receptor, alpha 2b |
GUANABENZ |
Adrenergic alpha2B |
100% |
.149uM |
.068uM |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
FLUVASTATIN |
HMG-CoA Reductase |
100% |
.000353uM |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
FLUVASTATIN |
HMG-CoA Reductase |
100% |
.000353uM |
NoneNone |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
HALCINONIDE |
Glucocorticoid |
100% |
.001611uM |
.000732uM |
View
|
| adrenergic receptor, alpha 2a |
CYPROHEPTADINE |
Adrenergic alpha2A |
100% |
.283uM |
.106uM |
View
|
| adrenergic receptor, alpha 2b |
CYPROHEPTADINE |
Adrenergic alpha2B |
100% |
.038uM |
.017uM |
View
|
| adrenergic receptor, alpha 2a |
PERGOLIDE |
Adrenergic alpha2A |
100% |
.264uM |
.099uM |
View
|
| prostaglandin-endoperoxide synthase 1 |
PIROXICAM |
Cyclooxygenase COX-1 |
100% |
1.313uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
PIROXICAM |
Cyclooxygenase COX-1 |
100% |
1.313uM |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
PERGOLIDE |
Serotonin 5-HT1B |
100% |
.087uM |
.04uM |
View
|
| adrenergic receptor, alpha 2b |
PERGOLIDE |
Adrenergic alpha2B |
100% |
.064uM |
.029uM |
View
|
| dopamine receptor D3 |
PERGOLIDE |
Dopamine D3 |
100% |
.005393uM |
.001832uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
PERGOLIDE |
Serotonin 5-HT1A |
100% |
.015uM |
.008468uM |
View
|
| 5-hydroxytryptamine receptor 6 |
PERGOLIDE |
Serotonin 5-HT6 |
100% |
.039uM |
.018uM |
View
|
| dopamine receptor 2 |
PROCHLORPERAZINE |
Dopamine D2L |
100% |
.011uM |
.003608uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
PERGOLIDE |
Serotonin 5-HT2B |
100% |
.076uM |
.049uM |
View
|
| monoamine oxidase A |
PHENELZINE |
Monoamine Oxidase MAOA |
100% |
.146uM |
NoneNone |
View
|
| monoamine oxidase A |
PHENELZINE |
Monoamine Oxidase MAOA |
100% |
.146uM |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
PROCHLORPERAZINE |
Sodium Channel, Site 2 |
100% |
1.265uM |
1.154uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
METERGOLINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.278uM |
.27uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
METERGOLINE |
Serotonin 5-HT1B |
100% |
.019uM |
.011uM |
View
|
| adrenergic receptor, alpha 1b |
DOMPERIDONE |
Adrenergic alpha1B |
100% |
.158uM |
.087uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
METERGOLINE |
Serotonin 5-HT4 |
100% |
1.641uM |
.274uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
METERGOLINE |
Serotonin 5-HT4 |
100% |
1.641uM |
.274uM |
View
|
| androgen receptor |
STANOLONE |
Testosterone |
100% |
.002305uM |
.001537uM |
View
|
| adrenergic receptor, alpha 2a |
METERGOLINE |
Adrenergic alpha2A |
100% |
.058uM |
.022uM |
View
|
| dopamine receptor D3 |
METERGOLINE |
Dopamine D3 |
100% |
.007689uM |
.002611uM |
View
|
| 5-hydroxytryptamine receptor 6 |
METERGOLINE |
Serotonin 5-HT6 |
100% |
.028uM |
.013uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| phosphodiesterase 4B, cAMP specific |
GENISTEIN |
Phosphodiesterase PDE4 |
74% |
10.924uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
METERGOLINE |
Calcium Channel Type L, Benzothiazepine |
100% |
.268uM |
.238uM |
View
|
| phosphodiesterase 5A, cGMP-specific |
SILDENAFIL |
Phosphodiesterase PDE5 |
100% |
.004577uM |
NoneNone |
View
|
| phosphodiesterase 5A, cGMP-specific |
SILDENAFIL |
Phosphodiesterase PDE5 |
100% |
.004577uM |
NoneNone |
View
|
| acetylcholinesterase (YT blood group) |
TACRINE |
Acetylcholinesterase |
100% |
.33uM |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
TACRINE |
Acetylcholinesterase |
100% |
.33uM |
NoneNone |
View
|
| acetylcholinesterase |
TACRINE |
Acetylcholinesterase |
100% |
.33uM |
NoneNone |
View
|
| aldo-keto reductase family 1, member B4 (aldose reductase) |
SULINDAC SULFONE |
Aldose Reductase |
100% |
.269uM |
NoneNone |
View
|
| aldo-keto reductase family 1, member B1 (aldose reductase) |
SULINDAC SULFONE |
Aldose Reductase |
100% |
.269uM |
NoneNone |
View
|
| aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
SULINDAC SULFONE |
Aldose Reductase |
100% |
.269uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Cyclooxygenase COX-2 |
100% |
.542uM |
NoneNone |
View
|
| A3 adenosine receptor |
MONTELUKAST |
Adenosine A3 |
100% |
.434uM |
.245uM |
View
|
| Cytochrom P450-2C19 monooxygenase |
OXICONAZOLE |
CYP450-2C19 Inhibition |
100% |
.04uM |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
TRIAMTERENE |
CYP450-2D6 Inhibition |
100% |
10uM |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
BROMHEXINE |
CYP450-2D6 Inhibition |
100% |
.1958uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
TERFENADINE |
Calcium Channel Type L, Phenylalkylamine |
100% |
.624uM |
.607uM |
View
|
